Risks of fulminant liver failure when stopping drugs for the management of hepatitis B
Risks of fulminant liver failure when stopping drugs for the management of hepatitis B
About this item
Full title
Risks of fulminant liver failure when stopping drugs for the management of hepatitis B
Journal title
Australian adverse drug reactions bulletin, 2008-12, Vol.27 (6), p.23
Formats
Subjects
More information
Scope and Contents
Contents
Hepatitis B can be effectively controlled by drugs which often need to be continued indefinitely. ADRAC is aware of at least 2 patients with previously well managed hepatitis B who developed fulminant liver failure requiring a transplant when they decided to stop taking their medication without medical advice. While this rebound phenomenon is well...
Alternative Titles
Full title
Risks of fulminant liver failure when stopping drugs for the management of hepatitis B
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_rmit_collectionsjats_10_3316_informit_561492623698754
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_rmit_collectionsjats_10_3316_informit_561492623698754
Other Identifiers
ISSN
0812-3837
How to access this item
Log in as a Library member
